scholarly journals CD4+ T cells persist for years in the human small intestine and display a TH1 cytokine profile

Author(s):  
Raquel Bartolomé-Casado ◽  
Ole J. B. Landsverk ◽  
Sudhir Kumar Chauhan ◽  
Frank Sætre ◽  
Kjersti Thorvaldsen Hagen ◽  
...  
1998 ◽  
Vol 114 (1) ◽  
pp. 115-122 ◽  
Author(s):  
Øyvind Molberg ◽  
Ellen M. Nilsen ◽  
Ludvig M. Sollid ◽  
Helge Scott ◽  
Per Brandtzaeg ◽  
...  

2020 ◽  
Author(s):  
Sudhir Kumar Chauhan ◽  
Raquel Bartolomé Casado ◽  
Ole J.B. Landsverk ◽  
Jørgen Jahnsen ◽  
Rune Horneland ◽  
...  

ABSTRACTGut resident regulatory CD4+ T (Tregs) cells in mice are mainly specific for intestinal antigens and play an important role in the suppression of immune responses against harmless dietary antigens and the gut microbiota. In contrast, information about the phenotype and function of Tregs in the human gut is limited. Here, we performed a detailed characterization of Foxp3+ CD4 Tregs in human small intestine (SI). SI Foxp3+ CD4 T cells were CD45RA-CTLA4+CD127- and suppressed proliferation of autologous T cells. Approximately 60% of SI Tregs expressed the transcription factor Helios. When stimulated, Helios- Tregs produced IL-17, IFNγ and IL-10, whereas Helios+ Tregs produced very low levels of these cytokines. Sampling mucosal tissue from transplanted human duodenum we demonstrated that donor SI Helios+ Tregs have a rapid turnover rate whereas Helios- Tregs persisted for at least 1 yr post transplantation. In the normal SI, Foxp3+ Tregs constituted only 2% of all CD4 T cells, while in active celiac disease both subsets expanded 5-10-fold. Taken together, these findings suggest that human SI contains two phenotypically and functionally distinct Treg subsets (Helios+ and Helios- Tregs), which are reminiscent of rapidly renewed dietary antigen-specific Tregs and microbiota-specific Tregs resident in the mouse gut, respectively.


1999 ◽  
Vol 128 (2) ◽  
pp. 380-384 ◽  
Author(s):  
B Y Kang ◽  
Y J Song ◽  
K -M Kim ◽  
Y K Choe ◽  
S Y Hwang ◽  
...  

2000 ◽  
Vol 130 (3) ◽  
pp. 581-586 ◽  
Author(s):  
B Y Kang ◽  
S W Chung ◽  
S H Kim ◽  
S N Kang ◽  
Y K Choe ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Corina Peña ◽  
David Gárate ◽  
Juan Contreras-Levicoy ◽  
Octavio Aravena ◽  
Diego Catalán ◽  
...  

Background. Pharmacologically modulated dendritic cells (DCs) have been shown to restore tolerance in type II collagen-(CII-) induced arthritis (CIA). We examined the effect of dexamethasone (DXM) administration as a preconditioning agent, followed by an injection of lipopolysaccharide-(LPS-) stimulated and CII-loaded DCs on the CIA course.Methods. After CIA induction, mice pretreated with DXM were injected with 4-hour LPS-stimulated DCs loaded with CII (DXM/4hLPS/CII/DCs).Results. Mice injected with DXM/4hLPS/CII/DCs displayed significantly less severe clinical disease compared to animals receiving 4hLPS/CII/DCs alone or those in which only DXM was administered. Cytokine profile evaluation showed that CD4+ T cells from DXM/4hLPS/CII/DCs and 4hLPS/CII/DCs groups release higher IL-10 levels than those from mice receiving DXM alone or CIA mice. CD4+ T cells from all DC-treated groups showed less IL-17 release when compared to the CIA group. On the contrary, CD4+ T cells from DXM/4hLPS/CII/DCs and 4hLPS/CII/DCs groups released higher IFN-γlevels than those from CIA group.Conclusion. A combined treatment, including DXM preconditioning followed by an inoculation of short-term LPS-stimulated CII-loaded DCs, provides an improved strategy for attenuating CIA severity. Our results suggest that this benefit is driven by a modulation in the cytokine profile secreted by CD4+ T cells.


2016 ◽  
Vol 150 (4) ◽  
pp. S578
Author(s):  
Jonathan Jacobs ◽  
Lin Lin ◽  
Venu Lagishetty ◽  
Paul Ruegger ◽  
James Borneman ◽  
...  
Keyword(s):  
T Cells ◽  

PLoS ONE ◽  
2016 ◽  
Vol 11 (7) ◽  
pp. e0158262 ◽  
Author(s):  
Kapil K. Saharia ◽  
Constantinos Petrovas ◽  
Sara Ferrando-Martinez ◽  
Manuel Leal ◽  
Rafael Luque ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document